Literature DB >> 24694338

Development of autoimmune overt hypothyroidism is highly associated with live births and induced abortions but only in premenopausal women.

Allan Carlé1, Inge Bülow Pedersen, Nils Knudsen, Hans Perrild, Lars Ovesen, Lone Banke Rasmussen, Peter Laurberg.   

Abstract

CONTEXT: The 1-year postpartum period is often accompanied by increased risk for thyroid disease.
OBJECTIVE: The objective of the study was to investigate the role of reproductive risk factors in the development of autoimmune overt hypothyroidism in the years after the 1-year postpartum period. DESIGN, SETTING, AND
SUBJECTS: In a population study, we included Danish women with new autoimmune overt hypothyroidism not diagnosed within the first year after a pregnancy (n = 117; median age 53.0 y) and age- and region-matched euthyroid controls from the same population (n = 468). MAIN OUTCOME MEASURES: In conditional multivariate logistic regression models, we analyzed the associations between the development of autoimmune hypothyroidism and age at menarche/menopause, years of menstruations, pregnancies, spontaneous and induced abortions, live births, and years on oral contraceptives and postmenopausal hormone replacement therapy, also taking various possible confounders into account.
RESULTS: In multivariate regression models with no event as reference, the odds ratios (ORs) for hypothyroidism [95% confidence interval (CI)] after one/two/three or more live births were 1.72 (0.56-5.32)/3.12 (1.14-8.48)/4.51 (1.65-12.3) and 1.02 (0.57-1.81)/2.70 (1.27-5.75) after one/two or more induced abortions. Findings were valid only for women having hypothyroidism diagnosed before the age of 55 years. We found no association between disease development and other reproductive risk factors investigated.
CONCLUSIONS: Previous live births and induced abortions were major risk factors for the development of autoimmune overt hypothyroidism in women aged up to 55 years. The increased risk for hypothyroidism after giving birth extends longer than just to the 1-year postpartum period, and numbers of previous pregnancies should be taken into account when evaluating the risk of hypothyroidism in a young women.

Entities:  

Mesh:

Year:  2014        PMID: 24694338     DOI: 10.1210/jc.2013-4474

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Pesticide use and incident hyperthyroidism in farmers in the Agricultural Health Study.

Authors:  Srishti Shrestha; Christine G Parks; Whitney S Goldner; Freya Kamel; David M Umbach; Mary H Ward; Catherine C Lerro; Stella Koutros; Jonathan N Hofmann; Laura E Beane Freeman; Dale P Sandler
Journal:  Occup Environ Med       Date:  2019-02-25       Impact factor: 4.402

2.  Previous Live Births and Induced Abortions May Precede Later Development of Graves' Hyperthyroidism.

Authors:  Allan Carlé; Nils Knudsen; Torben Jørgensen; Bettina Thuesen; Jesper Karmisholt; Stine Linding Andersen; Inge Bülow Pedersen
Journal:  Eur Thyroid J       Date:  2018-12-14

3.  Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study.

Authors:  Dorte Glintborg; Katrine Hass Rubin; Mads Nybo; Bo Abrahamsen; Marianne Andersen
Journal:  Endocr Connect       Date:  2019-10-01       Impact factor: 3.335

4.  Prolonged APTT and autoimmune overt hypothyroidism identified postpartum: a case report.

Authors:  Maja Hjelm Lundgaard; Allan Carlé; Ulla Birgitte Christiansen; Anne Sørensen; Søren Risom Kristensen; Stine Linding Andersen
Journal:  Eur Thyroid J       Date:  2022-07-15

5.  Abortion may be associated with elevated risk of future hypothyroidism.

Authors:  Vivek Chauhan; Anurag Thakur; Gurudutt Sharma
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Jan-Mar

6.  Environmental risk factors and comorbidities of primary biliary cholangitis in Korea: a case-control study.

Authors:  Kyung-Ah Kim; Young Seok Kim; Sang Hoon Park; Woo Jin Chung; Dae Hee Choi; Eun Sun Jang; Sook-Hyang Jeong
Journal:  Korean J Intern Med       Date:  2020-03-26       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.